|
No. |
Topic |
Summary |
Pages |
8233
| European Registration Authorities Requirements for NIR Applications | - | 35 |
8234
| Available Guidance on NIR | - | 30 |
8235
| Performing Quantitative NIR: Still a Challenge? | 2 | 43 |
8236
| NIR of Solid Dosage Forms - A Rational Approach to Determine Physical Properties and Dissolution Performance | - | - |
8237
| The Inherent Risk of Predicting Dissolution and other Values Using Correlative Techniques such as NIR - The Need for Process Understanding | - | - |
8238
| Introduction Presentation /Visit of AstraZeneca's Solid Dosage Form | - | 38 |
8239
| Continuous Monitoring of Sensor Performance for a Pharmaceutical Process | - | 38 |
8240
| Manufacturing of Insulin Suspensions: Quality and Yield Improvement | - | 21 |
8241
| NIR as a Tool for Real-time Moisture Monitoring for Lyophilisation Development of Parenterals | - | 28 |
8242
| IPC Blend Uniformity Testing | - | 42 |
8243
| At- /On-Line NIR as IPC tool During Granulation | - | 24 |
8244
| Spectroscopic Imaging - Unlocking Secrets of Solid Dosage Forms | - | 49 |
8245
| The Practicalities of NIR Calibration Transfer and Maintenance | - | 36 |
8246
| The PAT Challenge: - Selecting the Most Appropriate Technology to Identify and Control Real Critical Process Quality Needs
- Today's Regulatory Opportunities for Improving Business Performance
| - | - |
